Secretary-General's meeting with Bonda Development Group on product research and development with an approach to treating incurable diseases
According to the report of Public Relations and International Affairs of Council for Development of Stem Cell Sciences and Technologies, the meeting was held in the presence of Dr. Hamidieh, Secretary of council, Dr. Sadri, Engineer Marjavi, Chairman of the Board of Bonda Development Group and a number of company representatives.
At first, Dr. Bajuri, CEO of Viracell one of the subsidiaries of Bonda Development Group, introduced Bon Da. The group has so far worked in infrastructure areas such as rail, oil and gas and petrochemical lines, fossil and renewable power plants and biotechnology. Then, in the continuation of the meeting, they discussed the process of investment, research and development of products with the approach of treating incurable diseases such as cancer, infertility and extensive burns in the laboratory of Bonda Innovation Center.
ارسال به دوستان